| Buckeye Family Healthcare | |
|
3477 Commerce Parkway Suite A Wooster OH 44691-6109 | |
| (330) 601-0999 | |
| (330) 601-0935 |
| Full Name | Buckeye Family Healthcare |
|---|---|
| Speciality | Family Medicine |
| Location | 3477 Commerce Parkway, Wooster, Ohio |
| Authorized Official Name and Position | Kimberly I Williams (PRACTICE MANAGER) |
| Authorized Official Contact | 3306010999 |
| Accepts Medicare Insurance | Yes. This clinic participates in medicare program and accept medicare insurance. |
| Mailing Address | Practice Location Address |
|---|---|
| Buckeye Family Healthcare 3477 Commerce Pkwy Suite A Wooster OH 44691-7126 Ph: (330) 601-0999 | Buckeye Family Healthcare 3477 Commerce Parkway Suite A Wooster OH 44691-6109 Ph: (330) 601-0999 |
| NPI Number | 1235574500 |
|---|---|
| Provider Enumeration Date | 05/01/2013 |
| Last Update Date | 10/06/2016 |
| Medicare PECOS PAC ID | 3577705854 |
|---|---|
| Medicare Enrollment ID | O20130815000841 |
News Archive
"Funding by the United States for family planning has a giant positive impact," PSI's "Impact" blog writes, adding, "With the White House releasing its budget request for fiscal year 2014 and the budget debates heating up, now seems like a good time to look at what investments in reproductive health enables."
Millions of people around the world use acid suppressants called proton pump inhibitors for conditions like heartburn, gastritis and stomach ulcers. Researchers at Karolinska Institutet in Sweden now report that how the long-term use of these drugs could increase the risk of developing dementia.
Isis Pharmaceuticals, Inc., the leader in RNA-targeted therapeutics, and Akcea Therapeutics, its wholly owned subsidiary, announced today that The New England Journal of Medicine (NEJM) has published positive clinical results from a Phase 2 clinical study evaluating volanesorsen (formerly ISIS-APOCIII Rx) in patients with very high to severely high triglycerides.
A team led by University of Idaho scientists has found a way to stimulate formation of new neural connections in the adult brain in a study that could eventually help humans fend off memory loss, brain trauma and other ailments in the central nervous system.
› Verified 4 days ago
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1235574500 | NPI | - | NPPES |
| 2341942 | Medicaid | OH |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207Q00000X | Family Medicine | 35080332 (Ohio) | Primary |
| Provider Name | Scott Andrew Hannan |
|---|---|
| Provider Type | Practitioner - Family Practice |
| Provider Identifiers | NPI Number: 1366491797 PECOS PAC ID: 4082719638 Enrollment ID: I20070410000643 |
News Archive
"Funding by the United States for family planning has a giant positive impact," PSI's "Impact" blog writes, adding, "With the White House releasing its budget request for fiscal year 2014 and the budget debates heating up, now seems like a good time to look at what investments in reproductive health enables."
Millions of people around the world use acid suppressants called proton pump inhibitors for conditions like heartburn, gastritis and stomach ulcers. Researchers at Karolinska Institutet in Sweden now report that how the long-term use of these drugs could increase the risk of developing dementia.
Isis Pharmaceuticals, Inc., the leader in RNA-targeted therapeutics, and Akcea Therapeutics, its wholly owned subsidiary, announced today that The New England Journal of Medicine (NEJM) has published positive clinical results from a Phase 2 clinical study evaluating volanesorsen (formerly ISIS-APOCIII Rx) in patients with very high to severely high triglycerides.
A team led by University of Idaho scientists has found a way to stimulate formation of new neural connections in the adult brain in a study that could eventually help humans fend off memory loss, brain trauma and other ailments in the central nervous system.
› Verified 4 days ago
| Provider Name | Hannah E Miedel |
|---|---|
| Provider Type | Practitioner - Family Practice |
| Provider Identifiers | NPI Number: 1568435451 PECOS PAC ID: 0547291494 Enrollment ID: I20070815000160 |
News Archive
"Funding by the United States for family planning has a giant positive impact," PSI's "Impact" blog writes, adding, "With the White House releasing its budget request for fiscal year 2014 and the budget debates heating up, now seems like a good time to look at what investments in reproductive health enables."
Millions of people around the world use acid suppressants called proton pump inhibitors for conditions like heartburn, gastritis and stomach ulcers. Researchers at Karolinska Institutet in Sweden now report that how the long-term use of these drugs could increase the risk of developing dementia.
Isis Pharmaceuticals, Inc., the leader in RNA-targeted therapeutics, and Akcea Therapeutics, its wholly owned subsidiary, announced today that The New England Journal of Medicine (NEJM) has published positive clinical results from a Phase 2 clinical study evaluating volanesorsen (formerly ISIS-APOCIII Rx) in patients with very high to severely high triglycerides.
A team led by University of Idaho scientists has found a way to stimulate formation of new neural connections in the adult brain in a study that could eventually help humans fend off memory loss, brain trauma and other ailments in the central nervous system.
› Verified 4 days ago
| Provider Name | Lisa A Malys |
|---|---|
| Provider Type | Practitioner - Family Practice |
| Provider Identifiers | NPI Number: 1013172121 PECOS PAC ID: 5092985234 Enrollment ID: I20140624001289 |
News Archive
"Funding by the United States for family planning has a giant positive impact," PSI's "Impact" blog writes, adding, "With the White House releasing its budget request for fiscal year 2014 and the budget debates heating up, now seems like a good time to look at what investments in reproductive health enables."
Millions of people around the world use acid suppressants called proton pump inhibitors for conditions like heartburn, gastritis and stomach ulcers. Researchers at Karolinska Institutet in Sweden now report that how the long-term use of these drugs could increase the risk of developing dementia.
Isis Pharmaceuticals, Inc., the leader in RNA-targeted therapeutics, and Akcea Therapeutics, its wholly owned subsidiary, announced today that The New England Journal of Medicine (NEJM) has published positive clinical results from a Phase 2 clinical study evaluating volanesorsen (formerly ISIS-APOCIII Rx) in patients with very high to severely high triglycerides.
A team led by University of Idaho scientists has found a way to stimulate formation of new neural connections in the adult brain in a study that could eventually help humans fend off memory loss, brain trauma and other ailments in the central nervous system.
› Verified 4 days ago
| Provider Name | Mark A Stutzman |
|---|---|
| Provider Type | Practitioner - Family Practice |
| Provider Identifiers | NPI Number: 1659536761 PECOS PAC ID: 7315110434 Enrollment ID: I20140714001436 |
News Archive
"Funding by the United States for family planning has a giant positive impact," PSI's "Impact" blog writes, adding, "With the White House releasing its budget request for fiscal year 2014 and the budget debates heating up, now seems like a good time to look at what investments in reproductive health enables."
Millions of people around the world use acid suppressants called proton pump inhibitors for conditions like heartburn, gastritis and stomach ulcers. Researchers at Karolinska Institutet in Sweden now report that how the long-term use of these drugs could increase the risk of developing dementia.
Isis Pharmaceuticals, Inc., the leader in RNA-targeted therapeutics, and Akcea Therapeutics, its wholly owned subsidiary, announced today that The New England Journal of Medicine (NEJM) has published positive clinical results from a Phase 2 clinical study evaluating volanesorsen (formerly ISIS-APOCIII Rx) in patients with very high to severely high triglycerides.
A team led by University of Idaho scientists has found a way to stimulate formation of new neural connections in the adult brain in a study that could eventually help humans fend off memory loss, brain trauma and other ailments in the central nervous system.
› Verified 4 days ago
| Provider Name | Rachel Edgar |
|---|---|
| Provider Type | Practitioner - Nurse Practitioner |
| Provider Identifiers | NPI Number: 1790493864 PECOS PAC ID: 5294197810 Enrollment ID: I20230815000504 |
News Archive
"Funding by the United States for family planning has a giant positive impact," PSI's "Impact" blog writes, adding, "With the White House releasing its budget request for fiscal year 2014 and the budget debates heating up, now seems like a good time to look at what investments in reproductive health enables."
Millions of people around the world use acid suppressants called proton pump inhibitors for conditions like heartburn, gastritis and stomach ulcers. Researchers at Karolinska Institutet in Sweden now report that how the long-term use of these drugs could increase the risk of developing dementia.
Isis Pharmaceuticals, Inc., the leader in RNA-targeted therapeutics, and Akcea Therapeutics, its wholly owned subsidiary, announced today that The New England Journal of Medicine (NEJM) has published positive clinical results from a Phase 2 clinical study evaluating volanesorsen (formerly ISIS-APOCIII Rx) in patients with very high to severely high triglycerides.
A team led by University of Idaho scientists has found a way to stimulate formation of new neural connections in the adult brain in a study that could eventually help humans fend off memory loss, brain trauma and other ailments in the central nervous system.
› Verified 4 days ago
News Archive
"Funding by the United States for family planning has a giant positive impact," PSI's "Impact" blog writes, adding, "With the White House releasing its budget request for fiscal year 2014 and the budget debates heating up, now seems like a good time to look at what investments in reproductive health enables."
Millions of people around the world use acid suppressants called proton pump inhibitors for conditions like heartburn, gastritis and stomach ulcers. Researchers at Karolinska Institutet in Sweden now report that how the long-term use of these drugs could increase the risk of developing dementia.
Isis Pharmaceuticals, Inc., the leader in RNA-targeted therapeutics, and Akcea Therapeutics, its wholly owned subsidiary, announced today that The New England Journal of Medicine (NEJM) has published positive clinical results from a Phase 2 clinical study evaluating volanesorsen (formerly ISIS-APOCIII Rx) in patients with very high to severely high triglycerides.
A team led by University of Idaho scientists has found a way to stimulate formation of new neural connections in the adult brain in a study that could eventually help humans fend off memory loss, brain trauma and other ailments in the central nervous system.
› Verified 4 days ago
Family 1st Healthcare, Llc Primary Care Clinic Medicare: Not Enrolled in Medicare Practice Location: 3477 Commerce Pkwy, Suite A, Wooster, OH 44691 Phone: 330-345-8410 Fax: 330-345-8458 | |
Paul Nielsen Llc Primary Care Clinic Medicare: Not Enrolled in Medicare Practice Location: 128 E Milltown Rd, Suite 105, Wooster, OH 44691 Phone: 330-345-8060 Fax: 330-345-5983 | |
Wooster Family Wellness, Llc Primary Care Clinic Medicare: Not Enrolled in Medicare Practice Location: 3477 Commerce Pkwy, Suite A, Wooster, OH 44691 Phone: 330-601-0999 | |
Wooster Clinic, Llc Primary Care Clinic Medicare: Medicare Enrolled Practice Location: 1740 Cleveland Rd, Wooster, OH 44691 Phone: 330-287-4500 | |
My Clinic Primary Care Clinic Medicare: Not Enrolled in Medicare Practice Location: 306 Beall Ave, Wooster, OH 44691 Phone: 330-264-0247 Fax: 330-264-0463 | |
Wayne Internal Medicine Primary Care Clinic Medicare: Not Enrolled in Medicare Practice Location: 128 East Milltown Road, Suite 101, Wooster, OH 44691 Phone: 330-262-1700 Fax: 330-345-8980 |